Accessibility Menu
Getinge Ab (publ) logo

Getinge Ab (publ)(OTC) GNGBF

Current Price$22.49
Market Cap$6.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)+107%
5 Year-35%
1 Year+10%
1 Month+12%
Getinge Ab (publ) last closing stock price
MetricPriceDate
Last closeUSD 22.492026-07-23
Getinge Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+12.17%USD 20.052026-05-13
1 month+12.17%USD 20.052026-05-13
3 month-0.99%USD 22.712026-04-13
Year to date+4.07%USD 21.612025-12-19
1 year+9.53%USD 20.532025-07-09
3 year+32.12%USD 17.022023-07-21
5 year-35.06%USD 34.632021-07-20
Since inception+106.53%USD 10.892004-08-05

Getinge Ab (publ) Financials at a Glance

Market Cap

$6.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 34.18B

Net Income (TTM)

SEK 2.67B

EPS (TTM)

$1.05

P/E Ratio

21.46

Dividend

$0.52

Beta (Volatility)

0.10 (Low)

Price

$22.49

Volume

119

Open

$22.49

Previous Close

$22.49

Daily Range

$22.49 - $22.49

52-Week Range

$20.05 - $24.75

Estimated Earnings Date

Oct 20, 2026

GNGBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Getinge Ab (publ)

Getinge AB (publ) is a global provider of medical products and integrated solutions, primarily serving operating rooms, intensive care units, and sterilization departments. The company operates through three key segments: Acute Care Therapies, Life Science, and Surgical Workflows.

Products and Services
  • Advanced sterile transfer and processing systems
  • Patient monitoring and anesthesia machines
  • Bioreactors and bioprocess control systems
Growth Outlook
  • Revenue of 8.38 billion SEK in Q2 2026, up from 7.44 billion SEK in Q1 2026
  • Net income increased to 841 million SEK in Q2 2026
  • Strong demand in acute care and surgical environments supports future growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of 33.1 billion SEK
  • Operating income margin of 16.1% in Q2 2026
  • Dividend yield of 2.04% TTM, reflecting consistent shareholder returns
Getinge AB (publ) has established itself as a leader in the medical devices industry, with a diverse product portfolio that addresses critical healthcare needs. The company's recent financial performance indicates a robust growth trajectory, particularly in the acute care segment, which is expected to drive future revenues. The increase in net income and revenue in the latest quarter highlights the effectiveness of Getinge's operational strategies and market positioning. With a solid dividend yield, Getinge also demonstrates a commitment to returning value to shareholders, making it an attractive option for potential investors interested in the healthcare sector.
AI Generated • Jul 17, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

11,758

CEO

Mattias Sven Perjos

Website

www.getinge.com

Headquarters

Gothenburg, VG 417 56, SE

GNGBF Financials

Key Financial Metrics (TTM)

Gross Margin

47.57%

Operating Margin

13.56%

Net Income Margin

7.82%

Return on Equity

8.88%

Return on Capital

10.38%

Return on Assets

4.66%

Earnings Yield

4.66%

Dividend Yield

2.29%

Payout Ratio

49.03%

Stock Overview

Market Cap

$6.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

272.37M

Volume

119

Avg. Volume

3.952

Financials (TTM)

Gross Profit

SEK 16.34B

Operating Income

SEK 4.46B

EBITDA

SEK 6.48B

Operating Cash Flow

SEK 5.03B

Capital Expenditure

-SEK 1.23B

Free Cash Flow

SEK 3.80B

Cash & ST Invst.

SEK 2.05B

Total Debt

SEK 11.10B

Getinge Ab (publ) Performance Analysis

Getinge Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 2,795,681,619-11.3%
20232023-12-31SEK 2,998,037,6777.2%
20242024-12-31SEK 3,287,608,5069.7%
20252025-12-31SEK 3,565,533,3388.5%
Getinge Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-0.8%
Q42025-12-3124.7%
Q12026-03-31-26.9%
Q22026-06-3012.6%
Getinge Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK 0.90-28.9%
20232023-12-31SEK 0.83-7.7%
20242024-12-31SEK 0.57-31.8%
20252025-12-31SEK 0.8548.6%
Getinge Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.3%
Q42025-12-3154.9%
Q12026-03-31-53.9%
Q22026-06-30110.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SEK 8.38B

+1.7%

Gross Profit

SEK 4.42B

+12.1%

Gross Margin

52.69%

N/A

Market Cap

$6.13BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$521.15K

N/A

Employees

11,754

N/A

Net Income

SEK 841.00M

+60.5%

EBITDA

SEK 1.86B

+31.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SEK 2.05B

+5.5%

Total Debt

SEK 11.10B

-0.6%

Accounts Receivable

SEK 6.88B

+43.7%

Inventory

SEK 6.84B

+0.7%

Long Term Debt

SEK 9.09B

+1.3%

Short Term Debt

SEK 2.01B

-8.3%

Return on Assets

4.66%

N/A

Return on Invested Capital

10.24%

N/A

Free Cash Flow

SEK 995.00M

+96.6%

Operating Cash Flow

SEK 1.29B

+53.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AKBLFALK-Abelló A/S
$37.92+0.00%
FLMNFFielmann AG
$50.75+0.00%
CLCGYClicks Group Limited
$25.50-0.73%
NHNKYNihon Kohden Corporation
$9.23+0.47%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
FFord Motor Company
$14.37+0.02%

Questions About GNGBF

What is the current price of Getinge Ab (publ)?

Getinge Ab (publ) is trading at $22.49 per share.

What is the 52-week range for Getinge Ab (publ)?

Over the past 52 weeks, Getinge Ab (publ) has traded between $20.05 and $24.75.

How much debt does Getinge Ab (publ) have?

As of the most recent reporting period, Getinge Ab (publ) reported total debt of SEK 1.15B.

How much cash does Getinge Ab (publ) have on hand?

Getinge Ab (publ) reported SEK 212.02M in cash and cash equivalents in its most recent financial results.

What is Getinge Ab (publ)’s dividend yield?

Getinge Ab (publ) currently has a dividend yield of 2.29%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services